PuSH - Publikationsserver des Helmholtz Zentrums München

Meredith, L.W.* ; Hu, K.* ; Cheng, X. ; Howard, C.R.* ; Baumert, T.F.* ; Balfe, P.* ; van de Graaf, K.F.* ; Protzer, U. ; McKeating, J.A.

Lentiviral hepatitis B pseudotype entry requires NTCP and additional hepatocyte-specific factors.

J. Gen. Virol. 97, 121-127 (2016)
Verlagsversion Postprint DOI PMC
Open Access Green
Hepatitis B virus (HBV) is one of the world's major unconquered infections, resulting in progressive liver disease and current treatments rarely cure infection. A major limitation to discovering new therapies is our limited knowledge of HBV entry and dissemination pathways that hinders the development of in vitro culture systems. To address this gap in our understanding we optimised the genesis of infectious lentiviral pseudoparticles (HBVpp). The recent discovery that the bile salt transporter NTCP acts as a receptor for HBV enabled us to assess the receptor dependency of HBVpp infection. HBVpp preferentially infect hepatoma cells expressing NTCP, whereas other non-liver cells engineered to express NTCP do not support infection, suggesting that additional hepatocyte-specific factors are required for HBVpp internalisation. These results highlight the value of the HBVpp system to dissect the pathways of HBV entry and dissemination.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.192
0.967
12
13
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Virus; Glycoproteins; Resistant; Mutants; Assay
Sprache englisch
Veröffentlichungsjahr 2016
Prepublished im Jahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 0022-1317
e-ISSN 1465-2099
Quellenangaben Band: 97, Heft: , Seiten: 121-127 Artikelnummer: , Supplement: ,
Verlag Society for General Microbiology
Verlagsort Reading
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-003
PubMed ID 26474824
Erfassungsdatum 2015-11-11